Literature DB >> 8378109

Diet during rotavirus enteritis affects jejunal permeability to macromolecules in suckling rats.

E Isolauri1, M Kaila, T Arvola, H Majamaa, I Rantala, E Virtanen, H Arvilommi.   

Abstract

We studied the influence of diet during diarrhea on gut mucosal barrier in a suckling rat model. Rat pups were inoculated with IDIR virus (a group B rotavirus) at 10 d of age. Beginning 2 d postinfection, in addition to maternal milk, group CM received a daily gavage of cow milk and group GG received Lactobacillus casei strain GG, a human strain previously shown to survive the passage through the gastrointestinal tract and temporarily colonize the gut. Group CMGG received a combination of these, and control animals were gavaged with tap water. At 21 d of age, jejunal absorption of intact and degraded horseradish peroxidase (HRP) in Ussing chamber was markedly higher in IDIR virus-infected than in noninfected controls. In the two groups gavaged with cow milk, group CM and group CMGG, the numbers of specific antibody-secreting cells (enumerated by the solid-phase enzyme-linked immunospot assay) against beta-lactoglobulin were significantly higher than in the groups that had not received cow milk. In parallel with immune system activation, a statistically significant increase in the absorption of intact HRP (mean and 95% confidence interval, ng x h-1 x cm-2) was detected: group CM, 302 (155, 586); group CMGG, 174 (56, 545); infected controls, 121 (57, 257); and group GG, 44 (8, 254). A decrease in the uptake of intact HRP (F = 3.64, p = 0.06) and degraded HRP (F = 9.50, p = 0.004) was associated with the introduction of L. casei GG to the diet, irrespective of coexposure to cow milk.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8378109     DOI: 10.1203/00006450-199306000-00002

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  15 in total

1.  Intestinal zonulin: open sesame!

Authors:  A Fasano
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

Review 2.  Probiotics: a role in the treatment of intestinal infection and inflammation?

Authors:  E Isolauri; P V Kirjavainen; S Salminen
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

Review 3.  Do probiotics have a therapeutic role in gastroenterology?

Authors:  Jimmy K Limdi; Catherine O'Neill; John McLaughlin
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

Review 4.  Pathogen-induced secretory diarrhea and its prevention.

Authors:  S Anand; S Mandal; P Patil; S K Tomar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-29       Impact factor: 3.267

5.  Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function.

Authors:  Ravi M Patel; Loren S Myers; Ashish R Kurundkar; Akhil Maheshwari; Asma Nusrat; Patricia W Lin
Journal:  Am J Pathol       Date:  2011-12-05       Impact factor: 4.307

Review 6.  Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges.

Authors:  S Salminen; E Isolauri; E Salminen
Journal:  Antonie Van Leeuwenhoek       Date:  1996-10       Impact factor: 2.271

Review 7.  Developmental biology of gut-probiotic interaction.

Authors:  Ravi Mangal Patel; Patricia W Lin
Journal:  Gut Microbes       Date:  2010-05-26

8.  Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea.

Authors:  M Kaila; E Isolauri; M Saxelin; H Arvilommi; T Vesikari
Journal:  Arch Dis Child       Date:  1995-01       Impact factor: 3.791

Review 9.  Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

10.  Rotavirus infection increases intestinal motility but not permeability at the onset of diarrhea.

Authors:  Claudia Istrate; Marie Hagbom; Elena Vikström; Karl-Eric Magnusson; Lennart Svensson
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.